Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

NCT01350037 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Diseases
Pancreatic Diseases

Interventions

DRUG: alfentanil
DRUG: remifentanil

Sponsor

Helsinki University Central Hospital